Borna disease virus encoded phosphoprotein inhibits host innate immunity by regulating miR-155

Antiviral Research

Volumn 98, Issue 1, 2013, Pages 66-75

  Zhai, Aixia ^a   Qian, Jun ^a   Kao, Wenping ^a   Li, Aimei ^a   Li, Yujun ^a,b   He, Junming ^a   Zhang, Qingmeng ^a   Song, Wuqi ^a,b   Fu, Yingmei ^a   Wu, Jing ^a   Chen, Xiaobei ^a   Li, Hui ^a   Zhong, Zhaohua ^a   Ling, Hong ^a   Zhang, Fengmin ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b State Province Key Laboratories of Biomedicine Pharmaceutics of China   (China)

Author keywords

BDV; IFN; MiR 155; Persistent infection; SOCS

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERFERON; MESSENGER RNA; MICRORNA 155; PHOSPHOPROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ARTICLE; BORNA DISEASE VIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

BORNA DISEASE; BORNA DISEASE VIRUS; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MICRORNAS; PHOSPHOPROTEINS; VIRAL STRUCTURAL PROTEINS;

BORNA DISEASE VIRUS;

EID: 84874943814     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.02.009     Document Type: Article

References (20)

1. Androulidaki A., Iliopoulos D., Arranz A., Doxaki C., Schworer S., Zacharioudaki V., Margioris A.N., Tsichlis P.N., Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31:220-231.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Cameron J.E., Yin Q., Fewell C., Lacey M., McBride J., Wang X., Lin Z., Schaefer B.C., Flemington E.K. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 2008, 82:1946-1958.
4. Davis-Dusenbery B.N., Hata A. Mechanisms of control of microRNA biogenesis. J. Biochem. 2010, 148:381-392.
5. Haller O., Kochs G., Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344:119-130.
6. Hou J., Wang P., Lin L., Liu X., Ma F., An H., Wang Z., Cao X. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 2009, 183:2150-2158.
7. Huang J., Wang F., Argyris E., Chen K., Liang Z., Tian H., Huang W., Squires K., Verlinghieri G., Zhang H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 2007, 13:1241-1247.
8. Jiang S., Zhang H.W., Lu M.H., He X.H., Li Y., Gu H., Liu M.F., Wang E.D. MicroRNA-155 functions asan OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 2010, 70:3119-3127.
9. Lu F., Weidmer A., Liu C.G., Volinia S., Croce C.M., Lieberman P.M. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J. Virol. 2008, 82:10436-10443.
10. Lu L.F., Thai T.H., Calado D.P., Chaudhry A., Kubo M., Tanaka K., Loeb G.B., Lee H., Yoshimura A., Rajewsky K., Rudensky A.Y. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
11. MacMicking J.D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat. Rev. Immunol. 2012, 12:367-382.
12. Peng G., Zhang F., Zhang Q., Wu K., Zhu F., Wu J. Borna disease virus P protein inhibits nitric oxide synthase gene expression in astrocytes. Virology 2007, 366:446-452.
13. Qian J., Zhai A., Kao W., Li Y., Song W., Fu Y., Chen X., Zhang Q., Wu J., Li H., Zhong Z., Ling H., Zhang F. Modulation of miR-122 on persistently Borna disease virus infected human oligodendroglial cells. Antiviral Res. 2010, 87:249-256.
14. Scaria V., Hariharan M., Maiti S., Pillai B., Brahmachari S.K. Host-virus interaction: a new role for microRNAs. Retrovirology 2006, 3:68.
15. Shah A.A., Meese E., Blin N. Profiling of regulatory microRNA transcriptomes in various biological processes: a review. J. Appl. Genet. 2010, 51:501-507.
16. Tannahill G.M., Elliott J., Barry A.C., Hibbert L., Cacalano N.A., Johnston J.A. SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol. Cell. Biol. 2005, 25:9115-9126.
17. Triboulet R., Mari B., Lin Y.L., Chable-Bessia C., Bennasser Y., Lebrigand K., Cardinaud B., Maurin T., Barbry P., Baillat V., Reynes J., Corbeau P., Jeang K.T., Benkirane M. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315:1579-1582.
18. Unterstab G., Ludwig S., Anton A., Planz O., Dauber B., Krappmann D., Heins G., Ehrhardt C., Wolff T. Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc. Natl. Acad. Sci. USA 2005, 102:13640-13645.
19. Wang P., Hou J., Lin L., Wang C., Liu X., Li D., Ma F., Wang Z., Cao X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 2010, 185:6226-6233.
20. Weber F., Kochs G., Haller O. Inverse interference: how viruses fight the interferon system. Viral Immunol. 2004, 17:498-515.